Franklin Resources
ACHN

Franklin Resources’s Achillion Pharmaceuticals ACHN Stock Holding History

Franklin Resources’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,220,700
Closed -$12M – 1651
2015
Q1 		$12M Sell
1,220,700
-1,382,600
-53% -$17.3M 0.01% 1010
2014
Q4 		$31.9M Sell
2,603,300
-154,400
-6% -$1.89M 0.01% 752
2014
Q3 		$27.5M Buy
+2,757,700
New +$25.6M 0.01% 777
2013
Q3 		– Sell
-1,080,249
Closed -$8.84M – 1497
2013
Q2 		$8.84M Buy
+1,080,249
New +$8.25M 0.01% 972

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Franklin Resources's ACHN Position: Q2 2015 in Review

Franklin Resources sold out of Achillion Pharmaceuticals (ACHN) in Q2 2015, closing a stake of 1,220,700 shares — an estimated $12M sold.

Franklin Resources first reported a position in ACHN in Q2 2013 and held it in 4 quarters. The position peaked at $31.9M in Q4 2014. 158 funds tracked by Wall St. Rank hold ACHN as of Q2 2015.

  • Franklin Resources reported no remaining Achillion Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Franklin Resources sold 1,220,700 Achillion Pharmaceuticals shares in Q2 2015, an estimated $12M.
  • Franklin Resources first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Franklin Resources's Achillion Pharmaceuticals position peaked at $31.9M in Q4 2014.
  • 158 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2015.

Based on Franklin Resources's 13F filing for Q2 2015, filed 12 Aug 2015.